G17DT Completed Phase 3 Trials for Malignant Neoplasm of Pancreas Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03200821An Open Label Study to Evaluate G17DT Compared to Gemcitabine
NCT02118077Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer